Ranjit C. Desai,Rajesh Bahekar,Dipam Patel,Kiran Shah
申请号：
US15112536
公开号：
US09840509B2
申请日:
2015.02.02
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to heterocyclic compounds of the general formula (I) their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, enantiomers, diastereomers, and polymorphs. The invention also relates to processes for the preparation of the compounds of invention, pharmaceutical compositions containing the compounds and their use as selective Bruton's Tyrosine Kinase (BTK) inhibitors.
